Aligns With Analyst EPS Projections, Surpasses Net Income Estimates
Despite Challenges, Company Affirms Adjusted EPS and Raises Medicare Advantage Membership Growth Forecast
Comprehensive Analysis of Boston Scientific's First Quarter Financial Performance